Episode Details
Back to Episodes
EP446: GLP1 Agonists and Amazing Drugs! Father and Son Part 1
Description
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Introduction:
The podcast is hosted by Dr. Warrick Bishop, a cardiologist and CEO of the Healthy Heart Network, who focuses on promoting heart health and preventing heart disease. In this episode, Dr. Bishop is joined by his son, Max Bishop, a biomedical science student, to discuss GLP-1 agonists, a class of drugs that have gained attention for their roles in weight loss and diabetes management.
Key Takeaways:
- GLP-1 agonists, such as Ozempic and Wegovy, are drugs used for weight loss and diabetes management, originating from the discovery of incretins in the 1930s.
- Incretins are hormones produced in the small intestine that enhance insulin sensitivity and regulate hunger by affecting the hypothalamus.
- These drugs were initially developed for type 2 diabetes due to their ability to improve insulin sensitivity.
- The GLP-1 hormone has a very short half-life, leading to the development of synthetic analogs with longer-lasting effects.
- The first breakthrough in creating these drugs came from a compound found in the venom of the Gila monster, a lizard with a similar hormone that has a longer half-life.
- GLP-1 agonists suppress appetite and may reduce addictive behaviors related to food and alcohol, contributing to weight loss.
- The drugs help maintain metabolic rate during caloric deficit, preventing the typical slowdown in metabolism associated with dieting.
- Patients on these medications often experience significant appetite suppression, leading to reduced food intake and weight loss.
- Dr. Bishop notes that starting patients on a lower dose can help manage side effects like nausea.
- The use of GLP-1 agonists represents a novel approach by leveraging a natural signaling system to address modern health challenges.
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Australia, like the rest of the western world, has a heart problem.
Over 9 million people around the world die from heart disease every year.
Every 10 minutes, someone in Australia suffers a heart attack. And 21 lives are lost daily because of it.
The devastating fact in all of this is…
Almost every one of those cases could have been prevented.
This podcast is for anyone who wants to improve their health literacy and gain information to help them make the best decisions about their risk of heart attack, their cholesterol, blood pressure, risk of diabetes, weight loss and general health. Join me on my personal mission journey to prevent Heart Attack on a global scale. If you like this podcast, I would be honoured by a 5-star review and appreciate if you let your friends and family know about this podcast; you may even save the life of someone you love!
Are You at Risk of a Sudden Heart Attack? How Healthy is Your Heart? Really?
Heart disease is the #1 killer in the Western World. In Australia, someone dies every 28 minutes from heart disease. That’s 51 people a day. In the US, someone has a heart attack every 40 SECONDS! Fortunately, many heart attacks are preventable. However, regular exercise and eating healthy are no guarantee you won